Immune12 is a proprietary complex biologic derived from specific marine-sourced ingredients that may have potential anticancer properties based on preclinical studies and limited early phase human trials. If you would like more information, please contact us at info@pacificmarinebiotech.com.
Are you a medical professional looking for more information on Immune12? If so, click here.
Immune12 is taken orally, best if mixed with fruit juice or a non-alcoholic beverage. It can also be administered through a feeding tube or sipped through a straw.
The manufacturer of Immune12 is Unicorn Pacific Marketing, based in Vanuatu. To learn more about our manufacturer’s sustainability initiatives, please contact us at info@pacificmarinebiotech.com.
Adverse side effects have not been reported from patients taking Immune12 concurrently with standard of care.
Toxicity studies show that Immune12 has no toxicity, even at high doses.
There are currently no reported adverse side effects of Immune12. Some users may experience mild diarrhea during their first few days of use. People who are allergic to shellfish should consult their physician before taking Immune12.
Expanded access for Immune12 is currently unavailable.
If you cannot find the answer to your question, please contact Pacific Marine Biotech by filling out the following form.